Sign in

CIK 0001743881 · Large accelerated filer

BridgeBio Pharma, Inc.

Sign in to watch
Ticker
BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(650) 391-9740
Business address
3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
Former names
BridgeBio Pharma LLC
  1. 4 Shares withheld for taxes Chief Accounting Officer gave up 4,714 shares (to pay taxes)
  2. 4 Planned sale Director sold 10,000 shares at an average $67.15 ($671,456)
  3. 144 Insider Sale of Securities
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 8-K Event Other events
  6. 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $67.40 ($5,392,243)
  7. 8-K Event Material agreement · Agreement ended
  8. S-3ASR Offering Registration Statement
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations · Other events
  11. 4 Planned sale Chief Accounting Officer sold 2,000 shares at $71.58 ($143,160)
  12. ARS Other Annual Report to Security Holders
  13. DEFA14A Proxy Proxy Materials
  14. DEF 14A Proxy Proxy Statement
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $74.61 ($5,968,780)
  17. 144 Insider Sale of Securities
  18. SCHEDULE 13D/A Stake Beneficial Ownership Report
  19. 8-K Event Other events
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 4 of 42 · 834 filings